Arcturus Therapeutics Holdings (ARCT) Other financing activities (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Other financing activities data on file, last reported at $16000.0 in Q1 2026.

• Quarterly Other financing activities fell 91.79% year-over-year to $16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $406000.0 (down 85.2% YoY) and the FY2025 annual result came in at $585000.0, down 87.65% from the prior year.
• Other financing activities retreated to $16000.0 in Q1 2026, from $116000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.1 million in Q4 2024 to a low of -$3.9 million in Q3 2024.
• A 5-year average of $688642.9 and a median of $352500.0 in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities jumped 589.17% — and 2024, when it tumbled 859.03%.
• Tracing ARCT's Other financing activities over 5 years: stood at $768000.0 in 2022, then jumped by 168.1% to $2.1 million in 2023, then soared by 96.89% to $4.1 million in 2024, then tumbled by 97.14% to $116000.0 in 2025, then tumbled by 86.21% to $16000.0 in 2026.
• The last three Other financing activities figures came in at $16000.0 (Q1 2026), $116000.0 (Q3 2025), and $274000.0 (Q2 2025), per Business Quant data.